Market Access and Patient Activation
Delivering end-to-end services to ensure patients in the UK get efficient access to pharmaceutical therapeutics and diagnostics.


The NHS priorities and operational planning guidance for 2023/24 was released in December 2022. In episode six of Making Market Access Real, IQVIA experts, Steven Ferguson, Head of Market Access, UK and Arlene Neville, Associate Director - NHS Partnership and Engagement Lead, reflect on the key focus areas and what's next for the year ahead. Watch the full episode here.
You may also be interested in
Related solutions
Delivering end-to-end services to ensure patients in the UK get efficient access to pharmaceutical therapeutics and diagnostics.
Accelerating patient access to optimal care